Skip to main content
Catriona Jamieson, MD, Oncology, San Diego, CA

Catriona H Jamieson MD


Associate Professor, Medicine, UCSD School of Medicine

Join to View Full Profile
  • 200 W Arbor DrSan Diego, CA 92103

  • Phone+1 858-822-6276

  • Fax+1 858-822-6288

Dr. Jamieson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Stanford Health Care
    Stanford Health CareFellowship, Blood & Bone Marrow Transplant, 1999 - 2002
  • University of British Columbia
    University of British ColumbiaClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1999 - 2026
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Top Doctors:San Diego Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for...
    Catriona Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for...
    Catriona Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Results from a Phase 2 Study of Navitoclax in Combination with Ruxolitinib in Patients with Primary or Secondary Myelofibrosis
    Catriona Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Inflammatory Cytokine Responsive Enzymatic Mutagenesis Fuels Myeloproliferative Neoplasm Pre-Leukemia Stem Cell Evolution 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • RNA Modifications in Hematologic Malignancies 
    60th American Society of Hematology Annual Meeting - 12/2/2018
  • RNA Modifications in Hematology 
    60th American Society of Hematology Annual Meeting - 12/1/2018
  • Join now to see all

Press Mentions

  • Targeting Therapy-Resistant Pediatric Acute Myeloid Leukemia
    Targeting Therapy-Resistant Pediatric Acute Myeloid LeukemiaMarch 8th, 2023
  • UC San Diego’s Astrobiotechnology Hub to Drive Drug Discovery in Space
    UC San Diego’s Astrobiotechnology Hub to Drive Drug Discovery in SpaceFebruary 28th, 2023
  • Small Molecule Drug Reverses ADAR1-Induced Cancer Stem Cell Cloning Capacity
    Small Molecule Drug Reverses ADAR1-Induced Cancer Stem Cell Cloning CapacityFebruary 16th, 2023
  • Join now to see all

Grant Support

  • Exploring the Impact of Base Deaminase Deregulation on Precancer EvolutionUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2029

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: